Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis 1 and 2 (NF1 and NF2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01736267
What this trial is testing

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Who this might be right for
Bilateral Hearing Loss for Causes Other Than Tumors
Massachusetts Eye and Ear Infirmary 3
Not applicableStudy completedNCT03210285
What this trial is testing

WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaAcoustic Neuroma
University Hospital Tuebingen 70
Not applicableStudy completedNCT01222728
What this trial is testing

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

Who this might be right for
NeoplasmsNervous System DiseaseVestibular Disease
National Institute of Neurological Disorders and Stroke (NINDS) 5
Early research (Phase 1)WithdrawnNCT01850225
What this trial is testing

Feasibility Study of Auditory Brainstem Implant in Young Children

Who this might be right for
Bilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis
House Research Institute
Not applicableEnded earlyNCT01864291
What this trial is testing

Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects

Who this might be right for
Bilateral Hearing Loss for Causes Other Than Tumors
Massachusetts Eye and Ear Infirmary 9
Not applicableUnknownNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableUnknownNCT00004483
What this trial is testing

NF2 Natural History Consortium

Who this might be right for
Schwannoma, VestibularNeurofibromatosis 2Meningioma
House Ear Institute 100
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10
Not applicableStudy completedNCT02246231
What this trial is testing

Effect of Implant Position on Magnetic Resonance Image Distortion

Who this might be right for
Neurofibromatosis Type 2
Manchester University NHS Foundation Trust 5
Testing effectiveness (Phase 2)Study completedNCT01125046
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Who this might be right for
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Northwestern University 50
Not applicableNo Longer AvailableNCT02589912
What this trial is testing

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

Who this might be right for
Neurofibromatosis Type 2Severe Profound Sensorineural Hearing Loss
Massachusetts Eye and Ear Infirmary
Testing effectiveness (Phase 2)Study completedNCT02831257
What this trial is testing

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Who this might be right for
Neurofibromatosis 2Meningioma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05521048
What this trial is testing

Doxycycline in Cutaneous Schwannoma (NF2)

Who this might be right for
Neurofibromatosis Type 2
Massachusetts Eye and Ear Infirmary 19
Not applicableStudy completedNCT02298270
What this trial is testing

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Who this might be right for
NeurofibromatosisNeurofibromatosis INeurofibromatosis 2+1 more
Massachusetts General Hospital 65
Not applicableUnknownNCT04890132
What this trial is testing

Vestibular Precision: Physiology & Pathophysiology

Who this might be right for
Vestibular SchwannomaInner Ear DiseaseDizziness+2 more
Massachusetts Eye and Ear Infirmary 90
Early research (Phase 1)Study completedNCT02102256
What this trial is testing

A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients

Who this might be right for
Profound Bilateral Deafness Due toBilateral Cochlear AplasiaBilateral Cochlear Nerve Deficiency+1 more
Laurie Eisenberg 10
Not applicableStudy completedNCT02811718
What this trial is testing

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Who this might be right for
Neurofibromatosis 2
Massachusetts General Hospital 45
Not applicableLooking for participantsNCT03893643
What this trial is testing

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

Who this might be right for
Neurofibromatosis 2Dermatology/Skin - Other
Centre Hospitalier Universitaire de Nice 1,000
Large-scale testing (Phase 3)Ended earlyNCT05130866
What this trial is testing

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

Who this might be right for
Neurofibromatosis Type 2
Recursion Pharmaceuticals Inc. 25
Next Page